Impact of Implementing the Midwifery Model of Care on Maternal and Neonatal Health Outcomes in Ethiopia
Launched by DEBRE BERHAN UNIVERSITY · Feb 25, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a special approach to maternity care called the Continuity of Midwifery Care (CoMC), which is designed to provide women with consistent support from a dedicated group of midwives throughout their pregnancy, labor, and the early days after giving birth. The goal is to see if this model leads to better health outcomes for mothers and their newborns compared to the usual care they receive in hospitals. The trial will take place in Ethiopia and will involve 1,654 pregnant women who are less than 24 weeks along in their pregnancies.
To participate, women must be at least 18 years old, have a single pregnancy, and be considered low risk for complications. Unfortunately, those with certain medical issues or who plan to have a cesarean section will not be eligible. If chosen for the trial, participants will either receive care from a single midwife throughout their experience or the standard care provided by different staff members. The researchers will track important outcomes, such as the number of women who have a vaginal birth and how many babies are born prematurely. This study is not yet recruiting participants, but it aims to improve maternal and neonatal health in Ethiopia.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • All sampled pregnant women above 18 years with gestational age less than 24 whole weeks at the first ANC booking at the Government Hospitals
- • Singleton pregnancy, and
- • low obstetric risk.
- Exclusion Criteria:
- • Women who plan to have an elective cesarean section or
- • Women who have a history of medical or obstetric complications.
- • pregnant women who are unable to provide valid information due to mental, hearing, speech, or other medical issues that could worsen their current pregnancy will also be excluded.
- • pregnant mothers who are temporary residents and are expected to leave the study area before the 42-day postpartum period.
- • Women with a history of medical and obstetrics complications.
About Debre Berhan University
Debre Berhan University is a leading academic institution located in Ethiopia, committed to advancing health research and education. As a clinical trial sponsor, the university leverages its extensive resources and expertise to facilitate innovative research initiatives aimed at improving public health outcomes. With a focus on community engagement and collaboration, Debre Berhan University strives to address local and global health challenges through rigorous scientific inquiry and the promotion of evidence-based practices. The university's dedication to ethical research standards and its emphasis on capacity building position it as a vital contributor to the advancement of medical knowledge and healthcare solutions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported